Israeli regenerative medical materials developer CollPlant is to move ahead with its long-term “rhCollagen” project of developing 3D printed transplantable organs, thanks to a $5 million investment from US venture capital firm Alpha Capital in September. This news comes after CollPlant established an entire division dedicated to 3D printing in May of this year. CollPlant also filed […]
from 3D Printing Industry
viernes, 20 de octubre de 2017
10:01
MR: EDITOR
John
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation.
Related Posts